← All organizations

Indiana Hemophilia & Thrombosis Center

Academic/Hospital

Also known as: Indiana Hemophilia &Thrombosis Center, Inc.

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2001

Last known activity

Oct 31, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 6 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Recent trials (11)

  • NCT03265171CollaboratorN/A
  • NCT05317806Lead sponsorPhase 4Oct 31, 2022
  • NCT05317806Reponsible party - principal investigatorPhase 4Oct 31, 2022
  • NCT04567511Reponsible party - principal investigatorPhase 4Mar 31, 2021
  • NCT04567511Lead sponsorPhase 4Mar 31, 2021
  • NCT04567511Overall official - principal investigatorPhase 4Mar 31, 2021
  • NCT03921294Overall official - principal investigatorPhase 4May 31, 2019
  • NCT03921294Reponsible party - principal investigatorPhase 4May 31, 2019
  • NCT03921294Lead sponsorPhase 4May 31, 2019
  • NCT02690714Overall official - principal investigatorPhase 2/Phase 3May 4, 2016
  • NCT00157105Overall official - principal investigatorN/AFeb 1, 2001

Details

Last known activity
Oct 31, 2022